ANEXATE sol inj 0.5 mg/5ml 5 amp 5 ml
7680482800133
CH-48280
V03AB25
15.01.0.
1 / 3
google
Details
- Product number
- 4828001
- CPT
- -
- Packaging group
- 5 x 5 mL
- Unit
- Ampulle(n)
- Composition
- flumazenilum 0.1 mg, dinatrii edetas, acidum aceticum glaciale, natrii chloridum, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.67 mg.
Articles (1)
Anexate, Injektionslösung
Injektionslösung
5 x 5 mL
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.1 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.67 MG | Substance | HBESI |
Authorization holder
Cheplapharm Schweiz GmbH
4102 Binningen
Authorization information
- Swissmedic authorization number
- 48280
- Drug name
- Anexate, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- V03AB25
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/12/1986
- Authorization expiration date
- 31/12/9999
- IT number
- 15.01.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ANEXATE sol inj 0.5 mg/5ml 5 amp 5 ml
- Description (DE)
- ANEXATE Inj Lös 0.5 mg/5ml 5 Amp 5 ml
- Market launch
- 30/12/1986
- Narcotic (BTM)
- No